Intrinsic value of Imperva - IMPV

Previous Close

$56.85

  Intrinsic Value

$151.12

stock screener

  Rating & Target

str. buy

+166%

Previous close

$56.85

 
Intrinsic value

$151.12

 
Up/down potential

+166%

 
Rating

str. buy

We calculate the intrinsic value of IMPV stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 1.9

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  21.70
  20.03
  18.53
  17.17
  15.96
  14.86
  13.88
  12.99
  12.19
  11.47
  10.82
  10.24
  9.72
  9.24
  8.82
  8.44
  8.09
  7.79
  7.51
  7.26
  7.03
  6.83
  6.64
  6.48
  6.33
  6.20
  6.08
  5.97
  5.87
  5.79
Revenue, $m
  392
  470
  558
  653
  757
  870
  991
  1,119
  1,256
  1,400
  1,552
  1,710
  1,877
  2,050
  2,231
  2,419
  2,615
  2,819
  3,030
  3,250
  3,478
  3,716
  3,963
  4,220
  4,487
  4,765
  5,055
  5,356
  5,671
  5,999
Variable operating expenses, $m
  98
  117
  138
  161
  185
  212
  241
  272
  305
  339
  372
  410
  450
  491
  534
  580
  626
  675
  726
  779
  833
  890
  949
  1,011
  1,075
  1,142
  1,211
  1,283
  1,359
  1,437
Fixed operating expenses, $m
  278
  284
  290
  297
  303
  310
  317
  324
  331
  338
  346
  353
  361
  369
  377
  385
  394
  402
  411
  420
  430
  439
  449
  459
  469
  479
  489
  500
  511
  523
Total operating expenses, $m
  376
  401
  428
  458
  488
  522
  558
  596
  636
  677
  718
  763
  811
  860
  911
  965
  1,020
  1,077
  1,137
  1,199
  1,263
  1,329
  1,398
  1,470
  1,544
  1,621
  1,700
  1,783
  1,870
  1,960
Operating income, $m
  16
  70
  130
  196
  269
  348
  433
  524
  620
  722
  834
  947
  1,066
  1,190
  1,319
  1,454
  1,595
  1,741
  1,893
  2,051
  2,216
  2,387
  2,565
  2,750
  2,943
  3,144
  3,354
  3,573
  3,801
  4,039
EBITDA, $m
  28
  83
  145
  213
  288
  370
  457
  551
  650
  755
  866
  983
  1,105
  1,232
  1,365
  1,504
  1,649
  1,799
  1,955
  2,118
  2,287
  2,463
  2,646
  2,837
  3,036
  3,243
  3,458
  3,683
  3,918
  4,163
Interest expense (income), $m
  0
  0
  2
  5
  8
  12
  16
  20
  24
  29
  33
  39
  44
  50
  56
  62
  68
  75
  82
  89
  97
  105
  113
  121
  130
  139
  149
  159
  169
  180
  191
Earnings before tax, $m
  16
  67
  124
  188
  257
  332
  413
  500
  592
  689
  796
  904
  1,016
  1,134
  1,258
  1,386
  1,520
  1,659
  1,804
  1,954
  2,111
  2,274
  2,443
  2,620
  2,804
  2,996
  3,195
  3,404
  3,621
  3,848
Tax expense, $m
  4
  18
  34
  51
  69
  90
  112
  135
  160
  186
  215
  244
  274
  306
  340
  374
  410
  448
  487
  528
  570
  614
  660
  707
  757
  809
  863
  919
  978
  1,039
Net income, $m
  12
  49
  91
  137
  188
  242
  302
  365
  432
  503
  581
  660
  742
  828
  918
  1,012
  1,109
  1,211
  1,317
  1,427
  1,541
  1,660
  1,784
  1,913
  2,047
  2,187
  2,333
  2,485
  2,643
  2,809

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  405
  486
  577
  676
  783
  900
  1,025
  1,158
  1,299
  1,448
  1,604
  1,769
  1,941
  2,120
  2,307
  2,502
  2,704
  2,915
  3,134
  3,361
  3,597
  3,843
  4,098
  4,364
  4,640
  4,928
  5,227
  5,539
  5,865
  6,204
Adjusted assets (=assets-cash), $m
  405
  486
  577
  676
  783
  900
  1,025
  1,158
  1,299
  1,448
  1,604
  1,769
  1,941
  2,120
  2,307
  2,502
  2,704
  2,915
  3,134
  3,361
  3,597
  3,843
  4,098
  4,364
  4,640
  4,928
  5,227
  5,539
  5,865
  6,204
Revenue / Adjusted assets
  0.968
  0.967
  0.967
  0.966
  0.967
  0.967
  0.967
  0.966
  0.967
  0.967
  0.968
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
Average production assets, $m
  81
  97
  115
  135
  156
  179
  204
  231
  259
  288
  320
  352
  387
  422
  460
  498
  539
  581
  624
  669
  717
  765
  816
  869
  924
  982
  1,041
  1,103
  1,168
  1,236
Working capital, $m
  -6
  -8
  -9
  -10
  -12
  -14
  -16
  -18
  -20
  -22
  -25
  -27
  -30
  -33
  -36
  -39
  -42
  -45
  -48
  -52
  -56
  -59
  -63
  -68
  -72
  -76
  -81
  -86
  -91
  -96
Total debt, $m
  46
  98
  156
  219
  288
  363
  443
  528
  618
  714
  814
  919
  1,029
  1,144
  1,263
  1,388
  1,518
  1,652
  1,792
  1,938
  2,089
  2,246
  2,410
  2,580
  2,757
  2,941
  3,132
  3,332
  3,540
  3,757
Total liabilities, $m
  259
  311
  369
  432
  501
  576
  656
  741
  831
  927
  1,027
  1,132
  1,242
  1,357
  1,476
  1,601
  1,731
  1,865
  2,005
  2,151
  2,302
  2,459
  2,623
  2,793
  2,970
  3,154
  3,345
  3,545
  3,753
  3,971
Total equity, $m
  146
  175
  208
  243
  282
  324
  369
  417
  468
  521
  578
  637
  699
  763
  831
  901
  974
  1,049
  1,128
  1,210
  1,295
  1,383
  1,475
  1,571
  1,670
  1,774
  1,882
  1,994
  2,111
  2,233
Total liabilities and equity, $m
  405
  486
  577
  675
  783
  900
  1,025
  1,158
  1,299
  1,448
  1,605
  1,769
  1,941
  2,120
  2,307
  2,502
  2,705
  2,914
  3,133
  3,361
  3,597
  3,842
  4,098
  4,364
  4,640
  4,928
  5,227
  5,539
  5,864
  6,204
Debt-to-equity ratio
  0.320
  0.560
  0.750
  0.900
  1.020
  1.120
  1.200
  1.270
  1.320
  1.370
  1.410
  1.440
  1.470
  1.500
  1.520
  1.540
  1.560
  1.570
  1.590
  1.600
  1.610
  1.620
  1.630
  1.640
  1.650
  1.660
  1.660
  1.670
  1.680
  1.680
Adjusted equity ratio
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  12
  49
  91
  137
  188
  242
  302
  365
  432
  503
  581
  660
  742
  828
  918
  1,012
  1,109
  1,211
  1,317
  1,427
  1,541
  1,660
  1,784
  1,913
  2,047
  2,187
  2,333
  2,485
  2,643
  2,809
Depreciation, amort., depletion, $m
  12
  14
  15
  17
  20
  22
  24
  27
  30
  33
  32
  35
  39
  42
  46
  50
  54
  58
  62
  67
  72
  77
  82
  87
  92
  98
  104
  110
  117
  124
Funds from operations, $m
  24
  63
  106
  154
  207
  264
  326
  392
  462
  536
  613
  695
  781
  870
  964
  1,062
  1,163
  1,269
  1,379
  1,494
  1,613
  1,736
  1,865
  2,000
  2,139
  2,285
  2,437
  2,595
  2,760
  2,933
Change in working capital, $m
  -1
  -1
  -1
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -3
  -3
  -3
  -3
  -3
  -3
  -3
  -3
  -4
  -4
  -4
  -4
  -4
  -4
  -4
  -5
  -5
  -5
  -5
Cash from operations, $m
  25
  64
  108
  156
  209
  266
  328
  394
  464
  538
  615
  697
  783
  873
  967
  1,065
  1,166
  1,272
  1,382
  1,497
  1,616
  1,740
  1,869
  2,004
  2,144
  2,289
  2,441
  2,600
  2,765
  2,938
Maintenance CAPEX, $m
  -7
  -8
  -10
  -11
  -13
  -16
  -18
  -20
  -23
  -26
  -29
  -32
  -35
  -39
  -42
  -46
  -50
  -54
  -58
  -62
  -67
  -72
  -77
  -82
  -87
  -92
  -98
  -104
  -110
  -117
New CAPEX, $m
  -15
  -16
  -18
  -20
  -21
  -23
  -25
  -27
  -28
  -30
  -31
  -33
  -34
  -36
  -37
  -39
  -40
  -42
  -44
  -45
  -47
  -49
  -51
  -53
  -55
  -57
  -60
  -62
  -65
  -68
Cash from investing activities, $m
  -22
  -24
  -28
  -31
  -34
  -39
  -43
  -47
  -51
  -56
  -60
  -65
  -69
  -75
  -79
  -85
  -90
  -96
  -102
  -107
  -114
  -121
  -128
  -135
  -142
  -149
  -158
  -166
  -175
  -185
Free cash flow, $m
  4
  40
  80
  125
  174
  227
  285
  347
  413
  483
  555
  633
  714
  799
  887
  980
  1,076
  1,177
  1,281
  1,389
  1,502
  1,620
  1,742
  1,869
  2,002
  2,140
  2,284
  2,434
  2,590
  2,754
Issuance/(repayment) of debt, $m
  46
  52
  58
  63
  69
  75
  80
  85
  90
  95
  100
  105
  110
  115
  120
  125
  130
  135
  140
  146
  151
  157
  163
  170
  177
  184
  192
  200
  208
  217
Issuance/(repurchase) of shares, $m
  15
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  61
  52
  58
  63
  69
  75
  80
  85
  90
  95
  100
  105
  110
  115
  120
  125
  130
  135
  140
  146
  151
  157
  163
  170
  177
  184
  192
  200
  208
  217
Total cash flow (excl. dividends), $m
  65
  92
  138
  188
  243
  302
  365
  432
  503
  578
  655
  738
  824
  914
  1,007
  1,105
  1,206
  1,311
  1,421
  1,535
  1,653
  1,777
  1,905
  2,039
  2,178
  2,324
  2,475
  2,633
  2,798
  2,971
Retained Cash Flow (-), $m
  -26
  -29
  -32
  -36
  -39
  -42
  -45
  -48
  -51
  -54
  -56
  -59
  -62
  -65
  -67
  -70
  -73
  -76
  -79
  -82
  -85
  -88
  -92
  -96
  -99
  -104
  -108
  -112
  -117
  -122
Prev. year cash balance distribution, $m
  195
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  47
  57
  68
  81
  95
  110
  126
  144
  162
  182
  203
  225
  248
  272
  297
  323
  351
  379
  409
  439
  471
  504
  539
  575
  612
  651
  691
  733
  777
  822
Cash available for distribution, $m
  234
  62
  105
  152
  204
  260
  320
  384
  452
  524
  599
  679
  762
  849
  940
  1,034
  1,133
  1,235
  1,342
  1,453
  1,568
  1,688
  1,813
  1,943
  2,079
  2,220
  2,367
  2,521
  2,681
  2,849
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  224
  57
  92
  126
  158
  189
  216
  240
  260
  275
  284
  290
  290
  285
  276
  263
  247
  228
  207
  185
  162
  140
  119
  99
  81
  65
  51
  39
  29
  21
Current shareholders' claim on cash, %
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0
  98.0

Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company's products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.

FINANCIAL RATIOS  of  Imperva (IMPV)

Valuation Ratios
P/E Ratio -26.9
Price to Sales 7.1
Price to Book 8.1
Price to Tangible Book
Price to Cash Flow 85.5
Price to Free Cash Flow 376.2
Growth Rates
Sales Growth Rate 12.8%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 112.5%
Cap. Spend. - 3 Yr. Gr. Rate 41.5%
Financial Strength
Quick Ratio NaN
Current Ratio 0
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets -17.3%
Ret/ On Assets - 3 Yr. Avg. -21%
Return On Total Capital -29.7%
Ret/ On T. Cap. - 3 Yr. Avg. -40.7%
Return On Equity -29.7%
Return On Equity - 3 Yr. Avg. -40.7%
Asset Turnover 0.7
Profitability Ratios
Gross Margin 79.9%
Gross Margin - 3 Yr. Avg. 79.1%
EBITDA Margin -23.1%
EBITDA Margin - 3 Yr. Avg. -24.5%
Operating Margin -26.1%
Oper. Margin - 3 Yr. Avg. -27.3%
Pre-Tax Margin -26.1%
Pre-Tax Margin - 3 Yr. Avg. -27.3%
Net Profit Margin -26.5%
Net Profit Margin - 3 Yr. Avg. -27.8%
Effective Tax Rate -1.4%
Eff/ Tax Rate - 3 Yr. Avg. -1.8%
Payout Ratio 0%

IMPV stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the IMPV stock intrinsic value calculation we used $322 million for the last fiscal year's total revenue generated by Imperva. The default revenue input number comes from 2017 income statement of Imperva. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our IMPV stock valuation model: a) initial revenue growth rate of 21.7% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for IMPV is calculated based on our internal credit rating of Imperva, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Imperva.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of IMPV stock the variable cost ratio is equal to 25.2%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $272 million in the base year in the intrinsic value calculation for IMPV stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Imperva.

Corporate tax rate of 27% is the nominal tax rate for Imperva. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the IMPV stock is equal to 14.5%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for IMPV are equal to 20.6%.

Life of production assets of 10 years is the average useful life of capital assets used in Imperva operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for IMPV is equal to -1.6%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $315 million for Imperva - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 34 million for Imperva is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Imperva at the current share price and the inputted number of shares is $1.9 billion.

RELATED COMPANIES Price Int.Val. Rating
QLYS Qualys 97.05 22.99  str.sell
IBM International 146.35 149.81  hold
ORCL Oracle 48.52 48.84  hold
DVMT Dell Technolog 94.32 203.89  str.buy
SYMC Symantec 21.20 27.51  hold
INTC Intel 51.91 28.34  sell
CA CA 43.98 41.67  buy

COMPANY NEWS

▶ Imperva to Present at Upcoming Conferences   [May-08-18 08:00AM  Business Wire]
▶ Imperva: 1Q Earnings Snapshot   [Apr-26-18 06:02PM  Associated Press]
▶ Imperva Appoints David Woodcock to Lead Worldwide Sales   [Apr-11-18 04:30PM  Business Wire]
▶ Imperva to Report First Quarter 2018 Financial Results   [Apr-10-18 08:00AM  Business Wire]
▶ Imperva Announces Transition of Its Chairman of the Board   [Feb-21-18 04:03PM  Business Wire]
▶ Imperva to Present at Upcoming Investor Conferences   [Feb-20-18 04:15PM  Business Wire]
▶ Imperva beats 4Q profit forecasts   [Feb-08-18 06:11PM  Associated Press]
▶ Imperva, Inc. to Host Earnings Call   [01:30PM  ACCESSWIRE]
▶ How to Invest in Israel's Top Cybersecurity Stocks   [Jan-26-18 05:46PM  Motley Fool]
▶ Imperva Appoints David Gee as Chief Marketing Officer   [Jan-11-18 07:00AM  Business Wire]
▶ Imperva Appoints Mike Burns as CFO   [Jan-02-18 07:00AM  Business Wire]
▶ Imperva Named a Leader in DDoS Mitigation Solutions   [Dec-11-17 07:03AM  Business Wire]
▶ Imperva reports 3Q loss   [Nov-08-17 05:15PM  Associated Press]
▶ ETFs with exposure to Imperva, Inc. : October 27, 2017   [Oct-27-17 11:00AM  Capital Cube]
▶ Imperva Announces Chief Financial Officer Transition   [Oct-09-17 04:05PM  Business Wire]
▶ ETFs with exposure to Imperva, Inc. : August 1, 2017   [Aug-01-17 04:42PM  Capital Cube]
▶ Imperva reports 2Q loss   [12:03AM  Associated Press]
▶ Imperva Announces Second Quarter 2017 Financial Results   [Jul-27-17 04:05PM  Business Wire]
▶ ETFs with exposure to Imperva, Inc. : July 12, 2017   [Jul-12-17 02:41PM  Capital Cube]
▶ Imperva to Report Second Quarter 2017 Financial Results   [Jul-06-17 08:00AM  Business Wire]
▶ ETFs with exposure to Imperva, Inc. : June 27, 2017   [Jun-27-17 03:21PM  Capital Cube]
▶ Imperva to Present at Upcoming Investor Conferences   [May-30-17 08:00AM  Business Wire]
▶ Best Cyber Security Stocks To Buy Now   [May-15-17 01:32PM  Zacks]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.